Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
IPO Status: Listed [4th Aug 2023 to 8th Aug 2023]
Concord Biotech Limited is launching its IPO at NSE and BSE. This IPO is including only OFS whose issue size is 20,925,652 equity shares worth of Rs 1,551.00 Cr . You can apply in this IPO application from the subscription date of 04 Aug 2023 to 08 Aug 2023. The face value of each share is Rs 1. And the issue price band for this IPO is ranging from Rs 705 to Rs 741 per share along with the minimum quantity of lot size 20 shares or its multiple.
Keep visiting this website to get updated information about IPO details of Concord Biotech Limited including company overview, financials, live subscription, allotment, GMP and more.
| IPO Issue Opening Date: | 4th Aug 2023 |
| IPO Issue Closing Date: | 8th Aug 2023 |
| IPO Issue Price: | ₹705.00-741.00 Per Share |
| DRHP: | Download DRHP |
| RHP: | Download RHP |
| Anchor List: | Download Anchor List |
| IPO Listing At: | BSE, NSE |
| Retail Quota: | Not less than 35% of the Net Issue |
| IPO Issue Type: | Book Build Issue |
| IPO Issue Size: | ₹1551.00 Cr |
| Offer for Sale: | ₹1551.00 Cr |
| Face Value: | ₹1 Per Equity Share |
| IPO Discount: | Emplopee:70.00 |
| Promoter Holding Pre IPO: | 44.08% |
| Promoter Holding Post IPO: | 44.08% |
| Allotment Status: | Allotment Status |
| BSE Code: | 543960 |
| NSE Code: | CONCORDBIO |
Get important updates regarding Concord Biotech IPO tentative timeline covering IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.
| IPO Activity | Date |
|---|---|
| Basis of Allotment Date* | 11th Aug 2023 |
| Refunds Initiation* | 14th Aug 2023 |
| Credit of Shares to Demat* | 17th Aug 2023 |
| IPO Listing Date* | 18th Aug 2023 |
* - Tentative Dates
| IPO Activity | Date |
|---|---|
| Issue Price | ₹705.00-741.00 |
| Market Lot: | 20 Shares |
| 1 Lot Amount: | ₹14820 |
| Min Small HNI Lots(2-10 Lakh): | 280 shares (14 lots) |
| Min Big HNI Lots(10+ Lakh): | 1360 shares (68 lots) |
| GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Expected Listing Gain | Last Updated |
|---|---|---|---|---|---|
| 18-08-2023 | 741.00 | 122 | 1900/26600 | ₹863 (16.46%) | 18-Aug-2023 10:28 |
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
Founded in 1984, Concord Biotech Limited is an India-based biopharmaceutical company that is one of the world's leading developers and manufacturers of select fermentation-derived compounds in immunosuppressants and oncology, based on market share. In 2022, the company had a market share of over 20% in certain fermentatively produced agents, including mupirocin, sirolimus, tacrolimus, mycophenolate sodium and cyclosporine.
The Company manufactures (i) active pharmaceutical ingredients through fermentation and semi-synthetic processes in the therapeutic areas of immunosuppressants, oncology and anti-infectives and (ii) formulations for the therapeutic areas of immunosuppressants, nephrology and critical care anti-infectives. APIs are active pharmaceutical ingredients that, for example, prevent or cure diseases.
The company is one of the few in the world to have successfully and sustainably established and expanded production capacities for fermentation-based active ingredients. It has six active ingredients for fermentation-based immunosuppressants, including tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus and pimecrolimus. The Company intends to further expand its portfolio of immunosuppressants, which will continue to be an important contributor to the API business in the near future.
In addition to its portfolio of immunosuppressants, the Company intends to increase sales of its APIs in other therapeutic areas, particularly the following:
| Incorporation | Sector | IPO Issue Size | Website |
| 1984 | Pharmaceutical Industry | ₹1551.00 Cr | http://www.concordbiotech.com/ |
The objectives of the Offer are to:
Our experts can help you prepare for SME IPO
The table below is live update of IPO bidding details from NSE and BSE.
| Day | QIB | NII | RII | EMP | Total | |
|---|---|---|---|---|---|---|
| # of Shares Offered | 4,183,130 (28.55%) | 3,137,348 (21.41%) | 7,320,479 (49.97%) | 10,000 | 14,650,957 | |
| 1 | 4th Aug 2023 19:04 | 0.01x | 1.01x | 0.73x | 5.85x | 0.59x |
| 2 | 7th Aug 2023 19:04 | 1.61x | 5.22x | 2.27x | 15.90x | 2.72x |
| 3 | 8th Aug 2023 19:04 | 67.67x | 16.99x | 3.78x | 24.48x | 24.87x |
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 1,182.55 | 1,312.80 | 1,513.98 |
| Revenue | 630.75 | 736.35 | 888.48 |
| Profit After Tax | 234.89 | 174.93 | 240.08 |
| Net Worth | 999.37 | 1,103.22 | 1,290.00 |
| Reserves and Surplus | |||
| Total Borrowing | 86.35 | 60.59 | 31.24 |
Last Updated on 22-Aug-2023 06:00:21
Zerodha allows to apply online in IPOs via their back office software "console". UPI payment mode is to be used to apply online through Zerodha. To purchase Concord Biotech IPO with Zerodha, you must be Zerodha customer and have UPI payment setup. For more details please visit detailed article Step by Step Guide to apply Concord Biotech IPO with Zerodha.
Alternate approch to apply in Concord Biotech IPO is ASBA. You can use Zerodha DP information and apply online via ASBA with your prefered net banking user id.
Concord Biotech IPO Review and Important Updates
Other relevant questions :
How to subscribe Concord Biotech IPO Zerodha? How to purchase Concord Biotech IPO on Zerodha? Concord Biotech IPO how to buy Zerodha? Concord Biotech IPO Zerodha apply. Concord Biotech IPO purchase Zerodha. Concord Biotech IPO with Zerodha. Concord Biotech IPO at Zerodha. Concord Biotech IPO kite Zerodha. Concord Biotech IPO using Zerodha. Concord Biotech IPO via Zerodha.
To subscribe or apply in Concord Biotech IPO, you can use the following methods:
| Concord Biotech IPO Applying Mode | ||
| Online Application | 3-in-1 Trading Account | If your broker is 3-in-1 service provider, you can apply in Concord Biotech IPO directly with your brokers website. Example HDFC Securities, ICICI Direct, AxisDirect are 3-in-1 brokers provide you direct IPO investment. |
| Online Application | 2-in-1 Trading Account | Brokers like Zerodha, TradeSmart Online provides access to applying in Concord Biotech IPO with their in-house developed platform. You need to apply in IPO via UPI payment method. You must have access of your UPI mandate to apply in IPO online. |
| Online Application | ASBA | This is one of the most popular mode of applying in Concord Biotech IPO. Most of the Syndicate Banks provide access to apply in Concord Biotech IPO via ASBA process. You must have your net banking access, DP ID information to apply in Concord Biotech IPO via ASBA. Bank like Axis, SBI allows you to apply maximum 5 application from one bank account. However, ICICI, HDFC bank have limit of one IPO ASBA application per account. |
| Offline Application | Physical Form | You can apply in Concord Biotech IPO via physical form, but not with ASBA. Physical Forms need to be filled using UPI mode of payment and need to approve the mandate of UPI with your registered phone number with your UPI provider. You can use BHIM app or banks mobile app who support UPI process like SBI, HSBC, Axis, ICICI, HDFC, Yes Bank, Citi Bank mobile app. |
Concord Biotech IPO Review and Important Updates
Other relevant question on same topics are:
Where to subscribe Concord Biotech IPO? Where to apply for Concord Biotech IPO? How to subscribe Concord Biotech IPO online? Concord Biotech IPO where to apply? Where to buy Concord Biotech IPO online? How to buy Concord Biotech IPO online? How to purchase Concord Biotech IPO? How to get Concord Biotech IPO? How to book Concord Biotech IPO? How to invest Concord Biotech IPO? Concord Biotech IPO kaise buy kare?
Applying in Concord Biotech IPO is very easy and quick process via ASBA. You can use your net banking user id and password to apply in IPO. In case you want to submit physical application, you can download Concord Biotech IPO application online and submit to the nearest bank or to your broker. With new mandate from SEBI, all physical application need to use UPI mode of payment. In such case you have to setup UPI and provide your UPI information in physical application. Once your bank receives your application they will use UPI ID to block your money. You will get UPI mandate and need to approve the same to submit your application.
For more details on how to use UPI payment method to apply Concord Biotech IPO, please refer article >> Link
Concord Biotech IPO Review and Important Updates
Steps to download the online application form for Concord Biotech IPO
Or
Other relevant questions:
How to fill Concord Biotech IPO form? How to fill Concord Biotech IPO form online? Concord Biotech IPO online form? Concord Biotech IPO online form fill up? Concord Biotech IPO blank form download? Concord Biotech IPO bid form? Concord Biotech IPO full form? Concord Biotech IPO form nse? Concord Biotech IPO form bse? Concord Biotech IPO form online? Concord Biotech IPO form print? Concord Biotech IPO application amount?
Concord Biotech IPO is going to be list on 18-08-2023. NSE Code for Concord Biotech is CONCORDBIO. BSE Code for Concord Biotech is 543960.
Other relevant questions:
When Concord Biotech IPO will be listing? Concord Biotech IPO NSE listing date?Concord Biotech IPO date of listing.Concord Biotech IPO BSE listing date?
Concord Biotech IPO Allotment Date is 11-08-2023.
Other relevant questions:
Concord Biotech IPO share allotment date?Concord Biotech IPO allotment date?
